Brian Gaul, PharmD

home / authors / brian-gaul-pharmd

Articles

Pharmacist-Led Deprescribing Efforts Can Reduce Inappropriate Aspirin Use in Older Adults

Pharmacist-Led Deprescribing Efforts Can Reduce Inappropriate Aspirin Use in Older Adults

Brian Gaul, PharmD
July 9th 2024

Older adults who take aspirin for primary prevention of cardiovascular disease are at an increased risk of bleeding.

Read More

Biologics for Severe Asthma Present Opportunities for Pharmacists

Biologics for Severe Asthma Present Opportunities for Pharmacists

Brian Gaul, PharmD
May 2nd 2024

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.

Read More

Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

Brian Gaul, PharmD
April 16th 2024

The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD